Sifting through countless of stocks in the Biotechnology industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about ...

Sifting through countless of stocks in the Biotechnology industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about ...

Bath & Body Works (BBWI) is downgraded to hold due to weak guidance and deteriorating margins, despite ongoing buybacks. BBWI expects high single-digit revenue declines in Q4 2025 and further ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Nio has expanded its offerings by introducing two new brands, launching the mass-market brand Onvo and a new premium compact brand, Firefly, last year. This strategy to expand market reach has so far ...

After two years of radical underperformance, healthcare stocks more or less kept pace with the broad market in 2025.

Bath & Body Works hasn’t had a great year. Since the start of the year, BBWI fell from about $40 to $14.28. Now back to $19.79, it’s showing some signs of life again after tanking on earnings. The ...

Tylah Tully looks into Red Metal (ASX:RDM) and the much-anticipated testwork now underway over a unique rare earth project offering large tonnage potential southwest of Mt Isa. This video was ...